Ascendis Pharma A (ASND) Short-term Investments (2020 - 2025)

Ascendis Pharma A has reported Short-term Investments for 6 years, with the latest figure at $792.2 million in Q3 2025.

• Quarterly Short-term Investments rose 8.4% year-over-year to $792.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $792.2 million (up 8.4% YoY) and the FY2024 annual result came in at $777.4 million, up 64.41% from the prior year.
• Short-term Investments rose to $792.2 million in Q3 2025 per ASND's latest filing, from $686.2 million in the prior quarter.
• Over five years, Short-term Investments peaked at $1.1 billion in Q1 2022 and troughed at $1.8 million in Q2 2021.
• A 5-year average of $497.8 million and a median of $543.6 million in 2025 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2021 and 2022: Short-term Investments plunged 97.21% in 2021, then surged 57983.22% in 2022.
• Over 5 years, Short-term Investments stood at $5.2 million in 2021, then jumped by 233.77% to $17.3 million in 2022, then jumped by 2618.37% to $470.3 million in 2023, then jumped by 65.3% to $777.4 million in 2024, then increased by 1.91% to $792.2 million in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $792.2 million, $686.2 million, and $616.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.